Repisol Tablets 1 mg (Aripiprazole)

Adult dose

1. Schizophrenia - Recommended initial dose is either 10 mg or 15 mg once daily, regardless of meals. - The dose can be adjusted within the range of 10-30 mg daily; the dose should not be increased before 2 weeks, which is required to reach a steady state. - Efficacy for maintenance therapy has been established in clinical trials at a dose of 15 mg daily for the prevention of relapse in patients stabilized on antipsychotic treatment for more than 3 months. 2. Bipolar disorder and

Child dose

1. Schizophrenia (Adolescents 13-17 years) - Recommended dose is 10 mg once daily, regardless of meals. - Starting dose is 2 mg, followed by 5 mg after 2 days, and then 10 mg after another 2 days.

This medication may increase the risk of suicidal thoughts or behaviors in children or adolescents who have depression or psychiatric disorders, so it should be used with caution and under the supervision of a physician. Serious side effects may occur, including neuroleptic malignant syndrome; if symptoms like high fever, muscle rigidity, mental changes, or unstable blood pressure occur, notify medical staff immediately. Long-term use may lead to irreversible tardive dyskinesia; therefore, it should be administered at the lowest effective dose for the shortest duration possible, and consult a physician if symptoms arise. Elderly patients with dementia may have an increased risk of cerebrovascular accidents, including stroke, so it is advised not to use this medication for these patients. Diabetic patients should regularly monitor their blood sugar levels, as this medication may affect glucose control, and consult a physician if there are any signs of irregularities. There is a risk of thrombosis; therefore, patients with risk factors for thrombosis should be closely monitored before and during treatment with this medication. This medication may cause allergic reactions; thus, it should not be taken by patients with hypersensitivity. Orthostatic hypotension may occur, so caution is needed if dizziness or fainting symptoms are present. Patients with a history of seizures or those at high risk of seizures should exercise caution when taking this medication, as there may be an impairing effect on motor or cognitive abilities, particularly when driving or operating machinery. Thermoregulation may be impaired, so caution is required in hot environments or during intense physical activity. There is a risk of dysphagia or aspiration pneumonia; hence, elderly patients or those with impaired swallowing ability should be particularly cautious. During treatment, mental state changes such as anxiety, agitation, insomnia, and aggression may occur, so family members or caregivers should closely observe the patient's behavior changes. This medication is not approved for the treatment of pediatric depression and should not be used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Common side effects may include nausea, vomiting, constipation, headache, dizziness, restlessness, insomnia, drowsiness, fatigue, weight gain, etc. If abnormal symptoms persist or worsen, consult a physician.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweats, pallor, severe rash with high fever, blisters, skin peeling, mucosal pain in the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, breathing abnormalities with cough and fever, jaundice (skin or eyes turning yellow), severe drowsiness, sudden and severe headache, thunderclap headache, seizures, confusion, vision abnormalities, paralysis, urination

Mild side effects

• Nausea
• vomiting
• constipation
• headache
• dizziness
• akathisia
• anxiety
• insomnia
• restlessness
• drowsiness

Store this medication in a tightly closed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 °C and 30 °C at room temperature.

Appearance

White rectangular tablet

Package unit

30 tablets/bottle, 200 tablets/bottle